• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用血清内源性小分子谱分析技术鉴定鼻咽癌诊断和放化疗反应的生物标志物。

Identifying biomarkers for nasopharyngeal carcinoma diagnosis and chemoradiotherapy response using serum endogenous small molecules profiling.

机构信息

Department of Pharmacy, Eye and ENT Hospital, Fudan University, Shanghai 200031, China.

Department of Laboratory Medicine, Eye and ENT Hospital, Fudan University, Shanghai 200031, China.

出版信息

J Pharm Biomed Anal. 2024 Dec 15;251:116428. doi: 10.1016/j.jpba.2024.116428. Epub 2024 Aug 22.

DOI:10.1016/j.jpba.2024.116428
PMID:39208647
Abstract

Changes in metabolic characteristics are important features of tumor progression and prognosis, including nasopharyngeal carcinoma (NPC). Identifying serum metabolites as potential diagnostic and chemoradiotherapy response biomarkers for NPC is therefore crucial. In this study, ultra-performance liquid chromatography coupled with linear ion trap quadrupole orbitrap high-resolution mass spectrometry (UPLC-LTQ-Orbitrap MS) was used to analyze metabolic variations among controls, NPC patients, and NPC patients undergoing chemoradiotherapy (CRT). Univariate and multivariate analyses revealed seven differential metabolites between the control and NPC groups and eleven metabolites between the CRT and NPC groups. Five common metabolites, gluconic acid, palmitic acid, LysoPC (15:0/0:0), stearic acid, and LysoPC (20:2(11Z,14Z)/0:0), were consistently altered across groups. Notably, the first four metabolites were adjusted closer to normal after chemoradiotherapy, while this change is not reflected at LysoPC (20:2(11Z,14Z)/0:0). These common metabolites were enriched in five pathways. These findings underscore the importance of serum metabolite profiling in NPC diagnosis and treatment response assessment and offer a promising foundation for further clinical research.

摘要

代谢特征的改变是肿瘤进展和预后的重要特征,包括鼻咽癌(NPC)。因此,鉴定血清代谢物作为 NPC 的潜在诊断和放化疗反应生物标志物至关重要。在这项研究中,采用超高效液相色谱-线性离子阱四极杆轨道阱高分辨质谱联用技术(UPLC-LTQ-Orbitrap MS)分析了对照组、NPC 患者和接受放化疗(CRT)的 NPC 患者之间的代谢变化。单变量和多变量分析显示,对照组和 NPC 组之间有 7 种差异代谢物,CRT 组和 NPC 组之间有 11 种代谢物。5 种常见的代谢物,葡萄糖酸、棕榈酸、LysoPC(15:0/0:0)、硬脂酸和 LysoPC(20:2(11Z,14Z)/0:0),在各组中均发生改变。值得注意的是,前四种代谢物在放化疗后调整得更接近正常,而 LysoPC(20:2(11Z,14Z)/0:0)则没有这种变化。这些常见的代谢物富集在 5 条通路中。这些发现强调了血清代谢组学在 NPC 诊断和治疗反应评估中的重要性,并为进一步的临床研究提供了有希望的基础。

相似文献

1
Identifying biomarkers for nasopharyngeal carcinoma diagnosis and chemoradiotherapy response using serum endogenous small molecules profiling.采用血清内源性小分子谱分析技术鉴定鼻咽癌诊断和放化疗反应的生物标志物。
J Pharm Biomed Anal. 2024 Dec 15;251:116428. doi: 10.1016/j.jpba.2024.116428. Epub 2024 Aug 22.
2
Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma.血清和尿液代谢组学分析揭示了与鼻咽癌相关的代谢途径和生物标志物。
Rapid Commun Mass Spectrom. 2023 Mar 30;37(6):e9469. doi: 10.1002/rcm.9469.
3
Prognostic significance of platelet‑to‑albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.血小板-白蛋白比值对接受同期放化疗的鼻咽癌患者预后的意义:858 例回顾性研究。
BMC Cancer. 2024 Jun 25;24(1):762. doi: 10.1186/s12885-024-12499-w.
4
The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.循环肿瘤细胞中 COX-2 表达对鼻咽癌预后的价值:一项前瞻性分析。
Radiother Oncol. 2018 Nov;129(2):396-402. doi: 10.1016/j.radonc.2018.07.022. Epub 2018 Aug 3.
5
Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma.鼻咽癌患者同步性第二原发癌的预测因素——预处理年龄和血清乳酸脱氢酶
Oral Oncol. 2020 Nov;110:104990. doi: 10.1016/j.oraloncology.2020.104990. Epub 2020 Sep 12.
6
Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma.根治性放化疗后 S-1 维持化疗治疗 N3 期鼻咽癌患者。
Radiat Oncol. 2019 Oct 22;14(1):182. doi: 10.1186/s13014-019-1387-9.
7
Novel potential markers of nasopharyngeal carcinoma for diagnosis and therapy.新型鼻咽癌潜在诊断和治疗标志物。
Clin Biochem. 2011 Jun;44(8-9):711-8. doi: 10.1016/j.clinbiochem.2011.03.025. Epub 2011 Mar 21.
8
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.靶向 Epstein-Barr 病毒癌蛋白 LMP1 介导的高氧化应激抑制 EBV 裂解再激活并使肿瘤对放射治疗敏感。
Theranostics. 2020 Oct 25;10(26):11921-11937. doi: 10.7150/thno.46006. eCollection 2020.
9
Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.鉴定血浆中的 7 个 microRNA 特征作为鼻咽癌检测有前途的生物标志物。
Cancer Med. 2020 Feb;9(3):1230-1241. doi: 10.1002/cam4.2676. Epub 2019 Dec 19.
10
Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.循环 Epstein-Barr 病毒 microRNAs BART7-3p 和 BART13-3p 作为鼻咽癌的新型生物标志物。
Cancer Sci. 2020 May;111(5):1711-1723. doi: 10.1111/cas.14381. Epub 2020 Apr 9.